ArticleFrontiers in oncology2024

Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports.

Loc Carlo Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.